Mechanisms of change in negative thinking and urinary monoamines in depressed patients during acute treatment with group cognitive behavior therapy and antidepressant medication

Psychiatry Research

Volumn 175, Issue 1-2, 2010, Pages 82-88

  Dingle, Genevieve A ^a   Oei, Tian Po S ^a,b   Young, Ross McD ^c  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b Toowong Private Hospital   (Australia)

^c QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

Automatic thoughts; Cognitive behavior therapy; Depression; Dysfunctional attitudes; Urine monoamines

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; ANTIDEPRESSANT AGENT; DOPAMINE; HOMOVANILLIC ACID; METADRENALIN; MONOAMINE; NORADRENALIN; NORMETADRENALIN; SEROTONIN; VANILMANDELIC ACID;

ADOLESCENT; ADULT; AGED; ARTICLE; BECK DEPRESSION INVENTORY; BIOLOGICAL ACTIVITY; CATECHOLAMINE URINE LEVEL; CLINICAL ARTICLE; COGNITION; COGNITIVE THERAPY; CONTROLLED STUDY; DEPRESSION; FEMALE; HUMAN; MALE; METABOLITE; PATIENT ASSESSMENT; PRIORITY JOURNAL; REGULATORY MECHANISM; THERAPY EFFECT; TREATMENT DURATION; TREATMENT RESPONSE;

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; ANTIDEPRESSIVE AGENTS; BIOGENIC MONOAMINES; COGNITIVE THERAPY; DEPRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PERSONALITY INVENTORY; PSYCHIATRIC STATUS RATING SCALES; QUESTIONNAIRES; THINKING; TREATMENT OUTCOME; YOUNG ADULT;

EID: 72049103412     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psychres.2008.12.014     Document Type: Article

References (61)

1. Antoni M.H., Cruess D.G., Cruess S., Lutgendorf S., Kumar M., Ironson G., Klimas N., Fletcher M.A., and Schneiderman N. Cognitive-behavioral stress management intervention effects on anxiety, 24-hr urinary norepinephrine output, and T-cytotoxic/suppressor cells over time among symptomatic HIV-infected gay men. Journal of Consulting and Clinical Psychology 68 (2000) 31-45
2. American Psychiatric Association. Practice Guidelines for the Treatment of Patients with Major Depressive Disorder (Revision) (2000), American Psychiatric Press, Washington, DC
3. Bandura A., Taylor C.B., Williams S.L., Mefford I.N., and Barchas J.D. Catecholamine secretion as a function of perceived coping self-efficacy. Journal of Consulting and Clinical Psychology 53 (1985) 406-414
4. Beck A.T., Weissman A.W., Lester D., and Trexler L. The assessment of pessimism: the Hopelessness Scale. Journal of Consulting and Clinical Psychology 42 (1974) 861-865
5. Beck A.T., Kovacs M., and Weissman A. Hopelessness and suicidal behavior: an overview. Journal of the American Medical Association 234 (1975) 1146-1149
6. Beck A.T., Rush A.J., Shaw B.F., and Emery G. Cognitive Therapy of Depression (1979), New York, Guilford
7. Beck A.T., Steer R.A., and Garbin M.G. Psychometric properties of the Beck depression inventory: twenty-five years of evaluation. Clinical Psychology Review 8 (1988) 77-100
8. Brewin C.R. Cognitive change processes in psychotherapy. Psychological Review 96 (1989) 379-394
9. Davis B.A. Biogenic Monoamines and their Metabolites in Urine, Plasma, and CSF or Normal, Psychiatric and Neurological Subjects (1990), CRC Press, Florida
10. Davis J.M., Koslow S.H., Gibbons R.D., Maas J.W., Bowden C.L., Casper R., Hanin I., Javaid J.I., Chang S., and Stokes P.E. Cerebrospinal fluid and urinary biogenic amines in depressed patients and healthy controls. Archives of General Psychiatry 45 (1988) 705-717
11. DeRubeis R.J., Evans M.D., Hollon S.D., Garvey M.J., Grove W.M., and Tuason V.B. How does cognitive therapy work? Cognitive change and symptom change in cognitive therapy and pharmacotherapy for depression. Journal of Consulting and Clinical Psychology 58 6 (1990) 862-869
12. Durham T.W. Norms, reliability, and item analysis of the Hopelessness Scale in general psychiatric, forensic psychiatric, and college populations. Journal of Clinical Psychology 38 (1982) 597-600
13. Etkin A., Pittenger C., Polan H.J., and Kandel E.R. Toward a neurobiology of psychotherapy: basic science and clinical applications. Journal of Neuropsychiatry and Clinical Neurosciences 17 (2005) 145-158
14. Faustman W.O., Faull K.F., Whiteford H.A., Borchert C., and Csernansky J.G. CSF 5-HIAA, serum cortisol, and age differentially predict vegetative and cognitive symptoms in depression. Biological Psychiatry 27 (1990) 311-318
15. Fletcher H.P., Akbar W.J., Peoples R.W., and Spratto G.R. Effect of acute soman on selected endocrine parameters and blood glucose in rats. Fundamental and Applied Toxicology 11 (1988) 580-586
16. Free M., Oei T.P.S., and Sanders M. Treatment outcome of a group cognitive therapy program for depression. International Journal of Group Psychotherapy 41 (1991) 533-547
17. Free M.L., Oei T.P.S., and Appleton C. Biological and psychological processes in recovery from depression during cognitive therapy. Journal of Behavior Therapy and Experimental Psychiatry 29 (1998) 213-226
18. Friedman A., Dremencov E., Crown H., Levy D., Mintz M., Overstreet D.H., and Yadid G. Variability of the mesolimbic neuronal activity in a rat model of depression. Neuroreport: For Rapid Communication of Neuroscience Research 16 (2005) 513-516
19. Garratt G., Ingram R.E., Rand K.L., and Sawalani G. Cognitive processes in cognitive therapy: evaluation of the mechanisms of change in the treatment of depression. Clinical Psychology: Science and Practice 14 (2007) 224-239
20. Grossman F., and Potter W.Z. Catecholamines in depression: a cumulative study of urinary norepinephrine and its major metabolites in unipolar and bipolar depressed patients versus healthy volunteers at the NIMH. Psychiatry Research 87 (1999) 21-27
21. Hill C.V., Oei T.P.S., and Hill M.A. An empirical investigation of the specificity and sensitivity of the Automatic Thoughts Questionnaire and Dysfunctional Attitudes Scale. Journal of Psychopathology and Behavioral Assessment 11 (1989) 291-311
22. Hollon S.D., and Kendall P.C. Cognitive self statements in depression: development of an Automatic Thoughts Questionnaire. Cognitive Therapy and Research 4 (1980) 383-395
23. Hughes J.W., Watkins L., Blumenthal J.A., Kuhn C., and Sherwood A. Depression and anxiety symptoms are related to increased 24-hour urinary norepinephrine excretion among healthy middle-aged women. Journal of Psychosomatic Research 57 (2004) 353-358
24. Jacobson N.S., and Truax P. Clinical significance: a statistical approach to defining meaningful change in psychotherapy research. Journal of Consulting and Clinical Psychology 59 (1991) 12-19
25. Jindal R.D., and Thase M.E. Integrating psychotherapy and pharmacotherapy to improve outcomes among patients with mood disorders. Psychiatric Services 54 (2003) 1484-1490
26. Joffe R., Segal Z., and Singer W. Change in thyroid hormone levels following response to cognitive therapy for major depression. American Journal of Psychiatry 153 (1996) 411-413
27. Katz R., Katz J., and Shaw B.F. Beck Depression Inventory and Hopelessness Scale. In: Maruish M.E. (Ed). The Use of Psychological Testing for Treatment Planning and Outcomes Assessment. (2nd ed.) (1999), Lawrence Erlbaum Associates Publishers, Mahwah, NJ, US 921-933
28. Kitayama I., Nakamura S., Yaga T., Murase S., Nomura J., Kayahara T., and Nakano K. Degeneration of locus coeruleus axons in stress-induced depression model. Brain Research Bulletin 35 (1994) 573-580
29. Konrad K., Gauggel S., and Schurek J. Catecholamine functioning in children with traumatic brain injuries and children with attention-deficit/hyperactivity disorder. Cognitive Brain Research 16 (2003) 425-433
30. Kwon S.-M., and Oei T.P.S. Cognitive change processes in a group cognitive behavior therapy of depression. Journal of Behavior Therapy and Experimental Psychiatry 34 (2003) 73-85
31. Mancini C., and Brown G.M. Urinary catecholamines and cortisol in parasuicide. Psychiatry Research 43 (1992) 31-42
32. Mashige F., Matsushima Y., Miyata C., Yamada R., Kanazawa H., Sakuma J., Takai N., Shinozuka N., Ohkubo A., and Nakahara K. Simultaneous determination of catecholamines, their basic metabolites and serotonin in urine by high-performance liquid chromatography using a mixed-mode column and an eight-channel electrochemical detector. Biomedical Chromatography 9 (1995) 221-225
33. McAllister-Williams R.H., Ferrier I.N., and Young A.H. Mood and neuropsychological functions in depression: the role of corticosteroids and serotonin. Psychological Medicine 28 (1998) 573-584
34. Nair J.B., Munk M.N., and McLean J.D. Improved high-performance liquid chromatographic method with electrochemical detection for the determination of urinary catecholamines using a new electrochemical detector. Journal of Chromatography 15 (1987) 340-346
35. Oades R.D., Daniels R., and Rascher W. Plasma neuropeptide-Y levels, monoamine metabolism, electrolyte excretion and drinking behavior in children with attention-deficit hyperactivity disorder. Psychiatry Research 80 (1998) 177-186
36. Oei T.P.S. A Group Cognitive Behaviour Therapy Program for Mood Disorders (1996), Oei, Brisbane
37. Oei T.P.S., and Free M.L. Do cognitive behaviour therapies validate cognitive models of mood disorders?. International Journal of Psychology 30 (1995) 145-179
38. Oei T.P.S., and Sullivan L.M. Cognitive changes following recovery from depression in a group cognitive-behaviour therapy program. Australian and New Zealand Journal of Pschiatry 33 (1999) 407-415
39. Oei T.P.S., and Dingle G. Cognitive and biochemical processes in depressed adult outpatients: a test of the circular process model. Journal of Behavior Therapy and Experimental Psychiatry 32 (2001) 91-104
40. Oei, T.P.S., Dingle, G.A., 2008. The effectiveness of group cognitive behavior therapy for unipolar depressive disorders. Journal of Affective Disorders 107 (1-3), 5-21.
41. Oei T.P.S., Llamas M., and Devilly G.J. The efficacy and cognitive processes of cognitive behaviour therapy in the treatment of panic disorder with agoraphobia. Behavioural and Cognitive Psychotherapy 27 (1999) 63-88
42. Oei T.P.S., Bullbeck K., and Campbell J.M. Cognitive change process during group cognitive behaviour therapy for depression. Journal of Affective Disorders 92 (2006) 231-241
43. Oei, T.P.S., Dingle, G.A., & McCarthy, M. (submitted for publication). Urinary catecholamine levels and response to group cognitive behavior therapy for depression.
44. Oliver J.M., and Baumgart E.P. The Dysfunctional Attitudes scale: psychometric properties and relation to depression in an unselected adult population. Cognitive Research and Therapy 9 (1985) 161-167
45. Otto M.W., Smits J.A., and Reese H.E. Combined psychotherapy and pharmacotherapy for mood and anxiety disorders: review and analysis. Clinical Psychology: Science and Practice 12 (2005) 72-86
46. Owens M.J., and Nemeroff C.B. Role of serotonin in the pathophysiology of depression: focus on the serotonin transporter. Clinical Chemistry 40 (1994) 288-295
47. Pandey S.C., Ren X., Sagen J., and Pandey G.N. Beta-adrenergic receptor subtypes in stress-induced behavioral depression. Pharmacology, Biochemistry and Behaviour 51 (1995) 339-344
48. Reda M.A., Carpiniello B., Secchiaroli L., and Blanco S. Thinking, depression, and antidepressants: modified and unmodified depressive beliefs during treatment with amitriptyline. Cognitive Therapy and Research 9 2 (1985) 135-143
49. Rogeness G.A., Maas J.W., Javors M.A., Macedo C.A., Fischer C., and Harris W.R. Attention deficit disorder symptoms and urinary catecholamines. Psychiatry Research 27 (1989) 241-251
50. Simeon D., Gurlnik O., Knutelska M., Yehuda R., and Schmeidler J. Basal norepinephrine in depersonalization disorder. Psychiatry Research 121 (2003) 93-97
51. Simons A.D., Garfield S.L., and Murphy G.E. The process of change in cognitive therapy and pharmacotherapy for depression. Archives of General Psychiatry 41 (1984) 45-51
52. Smith K.A., Fairburn C.G., and Cowen P.J. Relapse of depression after rapid depletion of tryptophan. Lancet 349 (1997) 915-919
53. Smith K.A., Morris J.S., Friston K.J., Cowen P.J., and Dolan R.J. Brain mechanisms associated with depressive relapse and associated cognitive impairment following acute tryptophan depletion. British Journal of Psychiatry 174 (1999) 525-529
54. Southwick S.M., Bremner J.D., Rasmusson A., Morgan III C.A., Arnsten A., and Charney D.S. Role of norepinephrine in the pathophysiology and treatment of posttraumatic stress disorder. Biological Psychiatry 46 (1999) 1192-1204
55. Swann A.C., Stokes P.E., Secunda S.K., Maas J.W., Bowden C.L., Berman N., and Koslow S.H. Depressive mania versus agitated depression: biogenic amine and hypothalamic-pituitary-adrenocortical function. Biological Psychiatry 35 (1994) 803-813
56. Thase M.E., Fasiczka A.L., Berman S.R., Simons A.D., and Reynolds C.F. Electroencephalographic sleep profiles before and after cognitive behavior therapy of depression. Archives of General Psychiatry 55 (1998) 138-144
57. Tucker M., and Oei T.P.S. Is group more cost effective than individual cognitive behaviour therapy? The evidence is not solid yet. Behavioural and Cognitive Psychotherapy 35 (2007) 77-91
58. Viinamaki H., Kuikka J., Tiihonen J., and Lehtonen J. Change in monoamine transporter density related to clinical recovery: A case-controlled study. Nordic Journal of Psychiatry 52 (1998) 39-44
59. Weissman A.N., and Beck A.T. Development and validation of the Dysfunctional Attitudes Scale. Paper presented at the Association for the Advancement of Behavior Therapy annual meeting, Chicago (1978)
60. Yehuda R., Southwick S.M., Giller E.L., Ma X., and Mason J.W. Urinary catecholamine excretion and severity of PTSD symptoms in Vietnam combat veterans. Journal of Nervous and Mental Disease. 180 (1992) 321-325
61. Zangen A., Overstreet D.H., and Yadid G. High serotonin and 5-hydroxyindolacetic acid levels in limbic brain regions in a rat model of depression: normalization by chronic antidepressant treatment. Journal of Neurochemistry 69 (1997) 2477-2483